Merck Limited
| Facts and Figures | |
| Managing Director | Dr. Marek Dziki |
| Number of employees | Nearly 1300 (including out-sourced) across the Corporate, Pharmaceuticals and Chemicals businesses along with the Goa plant (as of Jan 2011) |
| Sales | Rs. 5090.8 million (2010) |
| Major products - Pharmaceuticals | Multi-vitamin products (Evion™, Neurobion™, Polybion™), Cardio-vascular Care (Concor™), Metabolic disorders (Carbophage™) and Haematinics (Livogen) |
| Major products – Consumer Health Care | Nasivion™, Femibion™, Evion™ cream, Maxepa™ and Kidbion™ |
| Major products – Performance Materials | We offer pigments for plastics, printing and coatings industries as well as for cosmetic applications. We are a market leader for pearl luster effect pigments |
| Research & Development | Merck’s state-of-the-art Galenic and Analytical Development Laboratory in Navi Mumbai, Maharashtra enables it to react faster to market demands, have better quality control and ensure world-class formulations by developing in-house various galenic forms like tablets, capsules, injections, syrups, dry powders, creams, etc. |
| Corporate Responsibility | The Merck India Charitable Trust Scholarship Programme was established in 2005 to encourage talented students in India to pursue higher education. The objective of the programme is to adopt these students by sponsoring their key educational expenses for as long as they wish to study and prevent them from dropping out of academics due to lack of resources. Following a contribution of Rs. 3 crores to the corpus, the Trust has financed the education of 168 students since its inception. |
